+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Home Infusion Therapy Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis

  • PDF Icon

    Report

  • 130 Pages
  • April 2022
  • Region: Global
  • Renub Research
  • ID: 5576809
Global Home Infusion Therapy Market is expected to reach US$ 45.46 Billion in 2027. Home infusion therapy is a medical approach that involves administering drugs or biologics to a patient at home via intravenous (IV) or subcutaneous injection. It entails the administration of medications such as antivirals or immune globin via various equipment such as pumps, catheters, and vials. For diabetes and other gastrointestinal and oncological disorders, the therapy is effective in chemotherapy and hydration, enteral, inotropic, anti-infective, nutritional, and pain management therapies. It allows patients to self-administer medications in situations where oral medications are ineffective.



Global Home Infusion Therapy Market Size is expanding with a CAGR of 8.43% during 2021-2027:


Patients have shifted from conventional treatments to specialty infusion therapy treatments such as home infusion therapy over the years. Furthermore, the home infusion therapy industry is adept at meeting the most complex patient requirements. The demand for home infusion therapy devices will increase in the coming years as the application spectrum of infusion devices expands, along with the growing demand for infusion devices in the home care market.

Furthermore, an aging population, a higher prevalence of chronic diseases, and the novelty of such therapeutic devices contribute to the overall market's growth. In contrast, associated risks during medication administration, irregularities in infusion device operation, incorrect use of infusion devices, and complex reimbursement policies may stifle market growth.

Covid-19 Pandemic Boosted the Home Infusion Market Across the World:


The Covid-19 pandemic had a favourable consequence on the home infusion market because the technique of home infusion was in high demand as healthcare facilities were overburdened with increasing numbers of Covid patients. Regional and national lockdowns significantly impacted operations and supply chains, yet the market grew substantially in 2020. As per the analysis, Global Home Infusion Therapy Market was US$ 27.97 Billion in 2021.

Product Insights Across Home Infusion Therapy Market Worldwide:


By product, the home infusion therapy market is divided into four categories: infusion pumps, intravenous sets, IV cannulas, and needleless connectors. According to the analysis, the infusion pumps segment will have significant market because these pumps are widely used for the delivery of nutrients and medications. The availability of a wide range of products, including enteral, syringe, multichannel, and peristaltic pumps, contributes to segment growth. The rising market for syringes and ambulatory pumps as people prefer home healthcare is also anticipated to contribute to segment growth. Moreover, smart pumps are now widely used because they include advanced features such as barcode technology, which aids in the verification of a patient's identity and prevents drug administration errors.

The Anti-Infective Dominates the Worldwide Home Infusion Therapy Market

In this report, Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, and Specialty Pharmaceuticals are the application segments of the market. According to the analysis, the anti-infective market dominates the global home infusion therapy market, owing to the large number of procedures performed to administer antifungal and antibiotic drugs. It also helps to reduce patient exposure to other hospital-acquired infections (HAIs).

Similarly, chemotherapy is expected to be one of the fastest-growing segments over the forecast period, owing to rising cancer incidences. Home chemotherapy pumps are compact and continuous pressure pumps that do not require a battery and can thus be used for a more extended period. Chemotherapy drugs can be dispensed at the appropriate infusion rate and amount with the help of these pumps. As a result, the demand for pressure pumps is expected to grow in the coming years.

Regional Realms of Global Home Infusion Therapy Market:


According to the analysis, North America will dominate the market in the forecast period. Primarily, due to the regions increased R&D and rising adoption of new technology in infusion pumps. The regional market is being driven by the increasing need for long-term therapy for patients with certain conditions. Furthermore, the development of alternative healthcare settings and home infusion services and the shift in appreciation from acute care to home care backdrops due to subordinate costs and increased patient mobility will propel the evolution of this market in the coming years.

Over the forecast period, the Asia Pacific market is expected to grow at the fastest rate. This is due to increased patient awareness of the advantages of home infusion therapy over in-hospital procedures and the region's rising diabetes prevalence. The region's growing geriatric population and rise in chronic diseases are expected to fuel market growth even further. According to the Times of India, as of January 7, 2021, approximately 75 million people over 60 in India suffer from a chronic condition, which may increase the country's adoption of home care services.

Key Companies:


We have studied the key players in this report, which include Johnson & Johnson Services, Inc., Pfizer Inc., Eli Lilly, Becton, Dickinson and Company, Baxter International Inc., Smith & Nephew plc, Terumo Corporation, and ICU Medical. The global market has been marked by fierce competition. The prompt adoptions of advanced healthcare technology for enhanced healthcare services are vital for market players' competitiveness. Furthermore, significant players frequently use mergers, acquisitions, and new product launches to maintain market share and diversify their product portfolio.

The publisher's latest report Home Infusion Therapy Market, Global Forecast By Product (Infusion Pump, Intravenous Sets, IV Cannulas and Needleless Connectors), Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals and Others) Region (North America, Europe, Asia Pacific, Latin America and Middle East and America), Companies (Johnson & Johnson Services, Inc., Pfizer Inc., Eli Lilly, Becton, Dickinson and Company, Baxter International Inc., Smith & Nephew plc, Terumo Corporation, and ICU Medical)” provides a detailed analysis of Global Home Infusion Therapy Industry.

Product -the Market has been covered from 4 viewpoints:


1. Infusion Pump
2. Intravenous Sets
3. IV Cannulas
4. Needleless Connectors

Application - the Market has been covered from 7 viewpoints:


1. Anti-infective
2. Hydration Therapy
3. Chemotherapy
4. Enteral Nutrition
5. Parenteral Nutrition
6. Specialty Pharmaceuticals
7. Others

Region - the Market has been covered from 5 viewpoints:


1. North America
2. Europe
3. Asia Pacific
4. Latin America
5. Middle East and America

Key Players Insight:


  • Overview
  • Recent Development
  • Revenue

Key Players:


1. Johnson & Johnson Services, Inc.
2. Pfizer Inc.
3. Eli Lilly
4. Becton, Dickinson and Company
5. Baxter International Inc.
6. Smith & Nephew plc
7. Terumo Corporation
8. ICU Medical
Frequently Asked Questions about the Global Home Infusion Therapy Market

What is the estimated value of the Global Home Infusion Therapy Market?

The Global Home Infusion Therapy Market was estimated to be valued at $27.97 Billion in 2021.

What is the growth rate of the Global Home Infusion Therapy Market?

The growth rate of the Global Home Infusion Therapy Market is 8.4%, with an estimated value of $45.46 Billion by 2027.

What is the forecasted size of the Global Home Infusion Therapy Market?

The Global Home Infusion Therapy Market is estimated to be worth $45.46 Billion by 2027.

Who are the key companies in the Global Home Infusion Therapy Market?

Key companies in the Global Home Infusion Therapy Market include Johnson & Johnson Services, Inc., Pfizer Inc., Eli Lilly, Becton, Dickinson and Company, Baxter International Inc., Smith & Nephew plc and ICU Medical.

Table of Contents

1. Introduction2. Research & Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Home Infusion Therapy Market
6. Market Share - Global Home Infusion Therapy Market
6.1 By Product
6.2 By Application
6.3 By Region
7. Product - Global Home Infusion Therapy Market
7.1 Infusion Pump
7.2 Intravenous Sets
7.3 IV Cannulas
7.4 Needleless Connectors
8. Application - Global Home Infusion Therapy Market
8.1 Anti-infective
8.2 Hydration Therapy
8.3 Chemotherapy
8.4 Enteral Nutrition
8.5 Parenteral Nutrition
8.6 Specialty Pharmaceuticals
8.7 Others
9. Region - Global Home Infusion Therapy Market
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East and America
10. Key Players
10.1 Johnson & Johnson Services, Inc.
10.1.1 Overview
10.1.2 Recent Development
10.1.3 Revenue
10.2 Pfizer Inc.
10.2.1 Overview
10.2.2 Recent Development
10.2.3 Revenue
10.3 Eli Lilly
10.3.1 Overview
10.3.2 Recent Development
10.3.3 Revenue
10.4 Becton, Dickinson and Company
10.4.1 Overview
10.4.2 Recent Development
10.4.3 Revenue
10.5 Baxter International Inc.
10.5.1 Overview
10.5.2 Recent Development
10.5.3 Revenue
10.6 Smith & Nephew plc
10.6.1 Overview
10.6.2 Recent Development
10.6.3 Revenue
10.7 Terumo Corporation
10.7.1 Overview
10.7.2 Recent Development
10.7.3 Revenue
10.8 ICU Medical
10.8.1 Overview
10.8.2 Recent Development
10.8.3 Revenue
List of Figures:
Figure 01: Global - Home Infusion Therapy Market (Billion US$), 2016 - 2021
Figure 02: Global - Forecast for Home Infusion Therapy Market (Billion US$), 2022 - 2027
Figure 03: Product - Infusion Pump Market (Million US$), 2016 - 2021
Figure 04: Product - Forecast for Infusion Pump Market (Million US$), 2022 - 2027
Figure 05: Product - Intravenous Sets Market (Million US$), 2016 - 2021
Figure 06: Product - Forecast for Intravenous Sets Market (Million US$), 2022 - 2027
Figure 07: Product - IV Cannulas Market (Million US$), 2016 - 2021
Figure 08: Product - Forecast for IV Cannulas Market (Million US$), 2022 - 2027
Figure 09: Product - Needleless Connectors Market (Million US$), 2016 - 2021
Figure 10: Product - Forecast for Needleless Connectors Market (Million US$), 2022 - 2027
Figure 11: Application - Anti-infective Market (Million US$), 2016 - 2021
Figure 12: Application - Forecast for Anti-infective Market (Million US$), 2022 - 2027
Figure 13: Application - Hydration Therapy Market (Million US$), 2016 - 2021
Figure 14: Application - Forecast for Hydration Therapy Market (Million US$), 2022 - 2027
Figure 15: Application - Chemotherapy Market (Million US$), 2016 - 2021
Figure 16: Application - Forecast for Chemotherapy Market (Million US$), 2022 - 2027
Figure 17: Application - Enteral Nutrition Market (Million US$), 2016 - 2021
Figure 18: Application - Forecast for Enteral Nutrition Market (Million US$), 2022 - 2027
Figure 19: Application - Parenteral Nutrition Market (Million US$), 2016 - 2021
Figure 20: Application - Forecast for Parenteral Nutrition Market (Million US$), 2022 - 2027
Figure 21: Application - Specialty Pharmaceuticals Market (Million US$), 2016 - 2021
Figure 22: Application - Forecast for Specialty Pharmaceuticals Market (Million US$), 2022 - 2027
Figure 23: Application - Others Market (Million US$), 2016 - 2021
Figure 24: Application - Forecast for Others Market (Million US$), 2022 - 2027
Figure 25: North America - Home Infusion Therapy Market (Million US$), 2016 - 2021
Figure 26: North America - Forecast for Home Infusion Therapy Market (Million US$), 2022 - 2027
Figure 27: Europe - Home Infusion Therapy Market (Million US$), 2016 - 2021
Figure 28: Europe - Forecast for Home Infusion Therapy Market (Million US$), 2022 - 2027
Figure 29: Asia Pacific - Home Infusion Therapy Market (Million US$), 2016 - 2021
Figure 30: Asia Pacific - Forecast for Home Infusion Therapy Market (Million US$), 2022 - 2027
Figure 31: Latin America - Home Infusion Therapy Market (Million US$), 2016 - 2021
Figure 32: Latin America - Forecast for Home Infusion Therapy Market (Million US$), 2022 - 2027
Figure 33: Middle East and America - Home Infusion Therapy Market (Million US$), 2016 - 2021
Figure 34: Middle East and America - Forecast for Home Infusion Therapy Market (Million US$), 2022 - 2027
Figure 35: Johnson & Johnson Services, Inc. - Global Revenue (Million US$), 2016 - 2021
Figure 36: Johnson & Johnson Services, Inc. - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 37: Pfizer Inc. - Global Revenue (Million US$), 2016 - 2021
Figure 38: Pfizer Inc. - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 39: Eli Lilly - Global Revenue (Million US$), 2016 - 2021
Figure 40: Eli Lilly - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 41: Becton, Dickinson and Company - Global Revenue (Million US$), 2016 - 2021
Figure 42: Becton, Dickinson and Company - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 43: Baxter International Inc. - Global Revenue (Million US$), 2016 - 2021
Figure 44: Baxter International Inc. - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 45: Smith & Nephew plc - Global Revenue (Million US$), 2016 - 2021
Figure 46: Smith & Nephew plc - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 47: Terumo Corporation - Global Revenue (Million US$), 2016 - 2021
Figure 48: Terumo Corporation - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 49: ICU Medical - Global Revenue (Million US$), 2016 - 2021
Figure 50: ICU Medical - Forecast for Global Revenue (Million US$), 2022 - 2027
List of Tables:
Table 01: Global - Home Infusion Therapy Market Share by Product (Percent), 2016 - 2021
Table 02: Global - Forecast for Home Infusion Therapy Market Share by Product (Percent), 2022 - 2027
Table 03: Global - Home Infusion Therapy Market Share by Application (Percent), 2016 - 2021
Table 04: Global - Forecast for Home Infusion Therapy Market Share by Application (Percent), 2022 - 2027
Table 05: Global - Home Infusion Therapy Market Share by Region (Percent), 2016 - 2021
Table 06: Global - Forecast for Home Infusion Therapy Market Share by Region (Percent), 2022 - 2027

Companies Mentioned

  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Eli Lilly
  • Becton, Dickinson and Company
  • Baxter International Inc.
  • Smith & Nephew plc
  • Terumo Corporation
  • ICU Medical

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...